BamSEC and AlphaSense Join Forces
Learn More

Monopar Therapeutics Inc. – Articles of Incorporation

NASDAQ: MNPR    
Share price (7/6/26): $97.12    
Market cap (7/6/26): $651 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Monopar Therapeutics Inc
12/34/56
EX-3.1
from 10-Q 8 pages Amended and Restated By-Laws of Monopar Therapeutics Inc
12/34/56
EX-3.2
from S-1/A 11 pages Amended and Restated By-Laws of Monopar Therapeutics Inc
12/34/56
EX-3.1
from S-1/A 5 pages Second Amended and Restated Certificate of Incorporation of Monopar Therapeutics Inc
12/34/56
EX-3.2
from S-1/A 11 pages Amended and Restated By-Laws of Monopar Therapeutics Inc
12/34/56
EX-3.1
from S-1/A 5 pages Second Amended and Restated Certificate of Incorporation of Monopar Therapeutics Inc
12/34/56
EX-3.2
from S-1/A 11 pages Amended and Restated By-Laws of Monopar Therapeutics Inc
12/34/56
EX-3.1
from S-1/A 5 pages Second Amended and Restated Certificate of Incorporation of Monopar Therapeutics Inc
12/34/56
EX-3.2
from S-1 11 pages Amended and Restated By-Laws of Monopar Therapeutics Inc
12/34/56
EX-3.1
from S-1 5 pages Second Amended and Restated Certificate of Incorporation of Monopar Therapeutics Inc
12/34/56
EX-3.2
from 10-K 11 pages Amended and Restated By-Laws of Monopar Therapeutics Inc
12/34/56
EX-3.1
from 10-K 5 pages Second Amended and Restated Certificate of Incorporation of Monopar Therapeutics Inc
12/34/56
EX-3.2
from 10-12G 11 pages Amended and Restated By-Laws of Monopar Therapeutics Inc
12/34/56
EX-3.1
from 10-12G 5 pages Second Amended and Restated Certificate of Incorporation of Monopar Therapeutics Inc
12/34/56